{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:33:05Z","timestamp":1789831985930,"version":"4.0.1"},"reference-count":35,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1136\/gutjnl-2016-311739","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T22:23:20Z","timestamp":1468362200000},"page":"137-144","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":81,"title":["Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis"],"prefix":"10.1136","volume":"66","author":[{"given":"Sebastian Torben","family":"Jendrek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gotthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nitzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Widmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Korf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike Anna","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaggelia","family":"Liaskou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Vesterhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Hemming","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swantje","family":"Mindorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"B\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Teegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph Matthias","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Fellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Derer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Roksund","family":"Hov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"key-10.1136\/gutjnl-2016-311739-1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"key-10.1136\/gutjnl-2016-311739-2","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a pre-malignant biliary tract disease: Surveillance and Management","volume":"13","author":"Rizvi","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.1136\/gutjnl-2016-311739-3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2016-311739-4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broom\u00e9","year":"2006","journal-title":"Semin Liver Dis"},{"key":"key-10.1136\/gutjnl-2016-311739-5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2011.10.002","article-title":"Primary sclerosing cholangitis and malignancy","volume":"25","author":"Boberg","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key-10.1136\/gutjnl-2016-311739-6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1385\/CRIAI:28:2:093","article-title":"Immunopathogenesis of primary sclerosing cholangitis","volume":"28","author":"Worthington","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"key-10.1136\/gutjnl-2016-311739-7","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key-10.1136\/gutjnl-2016-311739-8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040419","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis","volume":"11","author":"Rosen","year":"1991","journal-title":"Semin Liver Dis"},{"key":"key-10.1136\/gutjnl-2016-311739-9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/00365520600633495","article-title":"Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis","volume":"41","author":"Tischendorf","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"key-10.1136\/gutjnl-2016-311739-10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOG.0000000000000163","article-title":"Biomarkers for disease progression of primary sclerosing cholangitis","volume":"31","author":"de Vries","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"key-10.1136\/gutjnl-2016-311739-11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"key-10.1136\/gutjnl-2016-311739-12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.07.002","article-title":"MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response","volume":"11","author":"Iborra","year":"2012","journal-title":"Autoimmun Rev"},{"key":"key-10.1136\/gutjnl-2016-311739-13","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key-10.1136\/gutjnl-2016-311739-14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ecco-jcc\/jjv087","article-title":"Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn's patients: the importance of specific target antigens (GP2 and CUZD1)","volume":"9","author":"Papp","year":"2015","journal-title":"J Crohns Colitis"},{"key":"key-10.1136\/gutjnl-2016-311739-15","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1097\/MIB.0000000000000564","article-title":"Pancreatic autoantibodies against CUZD1 and GP2 are associated with Distinct Clinical Phenotypes of Crohn's Disease","volume":"21","author":"Michaels","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key-10.1136\/gutjnl-2016-311739-16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-407681-5.00006-4","article-title":"Glycoprotein 2 antibodies in Crohn's disease","volume":"60","author":"Roggenbuck","year":"2013","journal-title":"Adv Clin Chem"},{"key":"key-10.1136\/gutjnl-2016-311739-17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.crohns.2012.10.011","article-title":"Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2","volume":"7","author":"Komorowski","year":"2013","journal-title":"J Crohns Colitis"},{"key":"key-10.1136\/gutjnl-2016-311739-18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.cca.2010.12.029","article-title":"Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease","volume":"412","author":"Roggenbuck","year":"2011","journal-title":"Clin Chim Acta"},{"key":"key-10.1136\/gutjnl-2016-311739-19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4161\/gmic.1.6.14078","article-title":"Glycoprotein 2 (GP2): grabbing the FimH bacteria into M cells for mucosal immunity","volume":"1","author":"Ohno","year":"2010","journal-title":"Gut Microbes"},{"key":"key-10.1136\/gutjnl-2016-311739-20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/gastro\/gou066","article-title":"Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study","volume":"3","author":"Navaneethan","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"key-10.1136\/gutjnl-2016-311739-21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00054725-200411000-00012","article-title":"Pancreatic autoantibodies in inflammatory bowel disease","volume":"10","author":"Joossens","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"key-10.1136\/gutjnl-2016-311739-22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"key-10.1136\/gutjnl-2016-311739-23","article-title":"CD14 is associated with biliary stricture formation","author":"Friedrich","journal-title":"Hepatology"},{"key":"key-10.1136\/gutjnl-2016-311739-24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2016-311739-25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/gut.33.5.657","article-title":"Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis","volume":"33","author":"Seibold","year":"1992","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2016-311739-26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","article-title":"Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis","volume":"9","author":"Pokorny","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"key-10.1136\/gutjnl-2016-311739-27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.38.3.384","article-title":"Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass","volume":"38","author":"Bansi","year":"1996","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2016-311739-28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9343(98)00294-0","article-title":"Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features","volume":"105","author":"Roozendaal","year":"1998","journal-title":"Am J Med"},{"key":"key-10.1136\/gutjnl-2016-311739-29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"key-10.1136\/gutjnl-2016-311739-30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cca.2014.12.010","article-title":"Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA","volume":"441","author":"Pavlidis","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key-10.1136\/gutjnl-2016-311739-31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"key-10.1136\/gutjnl-2016-311739-32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"J\u00f8rgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key-10.1136\/gutjnl-2016-311739-33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-230X-9-58","article-title":"The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli type 1 Fimbriae","volume":"9","author":"Yu","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"key-10.1136\/gutjnl-2016-311739-34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"key":"key-10.1136\/gutjnl-2016-311739-35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2016-311739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T12:55:43Z","timestamp":1601038543000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2016-311739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,7]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/gutjnl-2016-311739"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2016-311739","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}